Lung cancer: A model for implementing stereotactic body radiation therapy into practice

Frontiers of Radiation Therapy and Oncology

Volumn 40, Issue , 2007, Pages 368-385

  Timmerman, R ^a   Abdulrahman, R ^a   Kavanagh, B D ^b   Meyer, J L ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Saint Francis Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HUMAN; LUNG TUMOR; METHODOLOGY; MOVEMENT (PHYSIOLOGY); PHASE 2 CLINICAL TRIAL; RADIATION DOSE; RADIOSURGERY;

CLINICAL TRIALS, PHASE II; HUMANS; LUNG NEOPLASMS; MOVEMENT; RADIOSURGERY; RADIOTHERAPY DOSAGE;

EID: 34547551811     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000106047     Document Type: Conference Paper

References (32)

1. Mountain CF: A new international staging system for lung cancer. Chest 1986;89:225S-233S.
2. Naruke T, Goya T, Tsuchiya R, et al: Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440-447.
3. Adebonojo SA, Bowser AN, Moritz DM, et al: Impact of revised stage classification of lung cancer on survival: a military experience. Chest 1999; 115:1507-1513.
4. Arriagada R, Bergman B, Dunant A, et al; International Adjuvant Lung Cancer Trial Collaborative Group: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350:351-360.
5. Ginsberg, RJ, Rubinstein LV: Randomized trial, of lobectomy versus limited resection for T1 NO non-small cell lung cancer. Ann Thorac Surg 1995;60:615-623.
6. Armstrong JG, Minsky BD: Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 1989;16:247.
7. Haffty BG, Goldberg NB, Gerstley J, et al: Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1988;15:69-73.
8. Kaskowitz L, Graham MV, Emami B, et al: Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993;27:517.
9. Dosoretz DE, Katin MJ, Blitzer PH, et al: Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992;24:3.
10. Dosoretz DE, Katin MJ, Blitzer PH, et al: Medically inoperable lung carcinoma: the role of radiation therapy. Semin Radiat Oncol 1996;6:98-104.
11. Sibley GS, Jamieson TA, Marks LB, et al: Radio-therapy alone for medically inoperable stage I non-small cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149-154.
12. Dosoretz DE, Galmarini D, Rubenstein JH, et al: Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 1993;27: 507-516.
13. Downey RJ: Surgical treatment of pulmonary metastases. Surg Oncol Clin N Am 1999;8:341.
14. Watanabe M, Deguchi H, Sato M, et al: Midterm results of thoracoscopic surgery for pulmonary metastases especially from colorectal cancers. J Laparoendosc Adv Surg Tech A 1998;8:195-200.
15. VanderMeer TJ, Gallery MP, Meyers WC: The approach to the patient with single and multiple liver metastases, pulmonary metastases, and intra-abdominal metastases from, colorectal carcinoma. Hematol Oncol Clin North Am 1997;11: 759-777.
16. Todd TR: Pulmonary metastectomy. Current indications for removing lung metastases. Chest 1993;103(4 suppl):401S-403S.
17. Ris HB, Vorburger T, Noce R, et al: Surgery and chemotherapy for pulmonary metastases: long-term results from a combined, modality approach. Thorac Cardiovasc Surg 1991;39:224-227.
18. Rosenzweig KE, Fox JL, Yorke E, et al: Results of a phase I dose-escalation study using three-dimensional conformai radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 2005;103:2118-2127.
19. Hayman JA, Martel MK, Ten Haken RK, et al: Dose escalation in non-small-cell lung cancer using three-dimensional conformai radiation therapy: update of a phase I trial. J Clin Oncol 2001;19:127-136.
20. Bradley J, Graham MV, Winter K, et al: Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005;61:318-328.
21. Mehta M, Scrimger R, Mackie R, et al: A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001;49:2333.
22. Machtay M, Hsu C, Komaki R, et al: Effect of overall treatment time on outcomes after concurrent chemoradiation or locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys 2005;63: 667-671.
23. Saunders M, Dische S, Barrett A, et al: Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomized multicentre trial. CHART Steering Committee. Lancet 1997;350:161-165.
24. Wolbarst AB, Chin LM, Svensson GK: Optimization of radiation therapy: integral-response of a model biological system. Int J Radiat Oncol Biol Phys 1982;8:1761-1769.
25. Yeas RJ, Kalend. A: Local stem cell depletion model, for radiation, myelitis. Int J Radiat Oncol. Biol Phys 1988;14:1247-1259.
26. Curran WJ, Moldofsky PJ, Solin LJ: Analysis of the influence of elective nodal irradiation, on. postirradiation, pulmonary function. Cancer 1990;65:2488-2493.
27. Krol AD, Aussems P, Noordijk EM, et al: Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996:34: 297-302.
28. Williams TE, Thomas CR Jr, Turrisi AT 3rd: Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Radiat Oncol 2000;10:308-314.
29. Shah RM, Edmonds P, Wechsler RJ, et al: Adjacent parenchymal abnormalities in peripheral bronchogenic carcinoma: correlation of thinsection CT with histology. J Thorac Imaging 2004;19:87-92.
30. Goldstein NS, Ferkowicz M, Kestin. L, et al: Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens. Am J Clin Pathol 2003;120:720-724.
31. Giraud P, Antoine M, Larrouy A, et al: Evaluation of microscopic tumor extension in. non-small-cell lung cancer for three-dimensional conformai radiotherapy planning. Int J Radiat Oncol Biol Phys 2000;48:1015-1024.
32. Timmerman R, Papiez L, McGarry R, et al: Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-1955.